July 15, 2024
Bioactive Peptide Market

The Burgeoning Customized Healthcare Industry Opening Up New Avenues For The Bioactive Peptide Market

Market Overview:

Bioactive peptides are short-chain amino acids derived from food sources such as milk, eggs and plant proteins that exert biological actions in the body. They help in various physiological functions like immunity, gut health, blood pressure regulation etc. Some common applications of bioactive peptides are in dietary supplements, functional foods and clinical nutrition. With increasing demand for customized nutrition and healthcare, bioactive peptides are gaining popularity as ingredients in personalized nutrition products.

Market Dynamics:

The growth of the bioactive peptide market is driven by rising health consciousness among consumers and growing demand for preventive healthcare through functional and dietary supplements. According to a study published in Nutrition Journal in 2019, the consumption of bioactive peptides from dairy, eggs and plant sources helps improve gut health, cardiovascular health and immunity. This has fueled the demand for bioactive peptides in food and beverage formulations. Additionally, the increasing incidence of lifestyle diseases such as obesity, diabetes etc. has also boosted the demand for specialized clinical nutrition products containing bioactive peptides. Manufacturers are extensively researching and developing customized peptide formulations for indications like weight management, glycemic control etc. The growing customized nutrition and healthcare industry presents significant business opportunities for players in the bioactive peptide market over the forecast period.

The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis

The global bioactive peptide market can be segmented based on type, application, and source.
Based on type, the collagen peptides segment accounts for the major market share and is anticipated to remain dominant over the forecast period. This segment is expected to dominate due to exponentially increasing collagen supplement consumption globally.

PEST Analysis

Political: The bioactive peptide market is driven by increasing government focus on healthcare and preventive measures. For instance, provision of tax benefits on health supplement production boosts the market.
Economic: Rising per capita income allows higher spending on healthcare and wellness products worldwide, thereby fueling the market.
Social: Growing awareness among consumers about the health benefits of peptides in preventing diseases propels the market.
Technological: Advancements in fermentation and extraction technologies facilitate large-scale and cost-effective production of peptides, encouraging market growth.

Key Takeaways

The global bioactive peptide market size was valued at US$ 9.8 billion in 2023 and is expected to reach US$ 16.7 billion by 2030, expanding at a CAGR of 9.4% during the forecast period. Rapid growth in preventive healthcare adoption and rising health supplement consumption are expected to drive the market.
Regional analysis: North America captured over 35% of the global market share in 2023 and is expected to continue dominance over the forecast period. This can be attributed to rising health consciousness and increasing adoption of bioactive supplements in the region.

Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, visited, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it